{
  "data": {
    "id": "stat_TBT0EHZB6AJK58HZ51FA8ABSBW",
    "url": "https://statorigin.org/stat/stat_TBT0EHZB6AJK58HZ51FA8ABSBW",
    "indicator": {
      "slug": "new-medicines-availability-rate",
      "name": "New medicines availability rate",
      "definition": "Percentage of newly approved medicines made fully accessible for their licensed indications."
    },
    "industry": [
      {
        "slug": "pharmaceuticals",
        "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
        "isic": "C21",
        "is_primary": true
      }
    ],
    "region": {
      "code": "GB",
      "name": "United Kingdom",
      "type": "country"
    },
    "period": {
      "start": "2021-01-01",
      "end": "2024-12-31",
      "type": "year"
    },
    "value": 33,
    "value_text": "33 per cent",
    "unit": "percent",
    "currency": null,
    "scale": "1",
    "value_type": "actual",
    "source": {
      "org": "Association of the British Pharmaceutical Industry",
      "org_short_name": "ABPI",
      "org_url": "https://www.abpi.org.uk",
      "org_tier": 2,
      "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
      "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
      "document_type": "press_release",
      "locator": "UK competitive weaknesses",
      "quote": "Just 33 per cent of new medicines were made fully available for their licensed use in 2021–24, and the UK ranks last among European comparators for how adoption of new, innovative medicines.",
      "published_date": null,
      "accessed_at": "2026-09-17",
      "license": "see-source",
      "url_status": "ok"
    },
    "verification": "verified",
    "verified_by": "seed:auto-extract-v1",
    "verified_at": "2026-09-17T07:16:01.811Z",
    "confidence": 0.9,
    "is_secondhand": false,
    "supersedes": null,
    "superseded_by": null,
    "is_current": true,
    "citation": {
      "apa": "Association of the British Pharmaceutical Industry. (2024). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_TBT0EHZB6AJK58HZ51FA8ABSBW",
      "bibtex": "@misc{abpi2024medicines8absbw,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_TBT0EHZB6AJK58HZ51FA8ABSBW},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
    },
    "updated_at": "2026-09-17T07:16:01.811Z",
    "contested_by": [],
    "related": []
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}